You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

20 Results
Drug
Other Name(s): Vidaza®
Aug 2023
Drug
Other Name(s): Oncaspar®
Dec 2022
Drug
Other Name(s): Besponsa®
Jul 2023
Drug
Other Name(s): Unituxin®
Jun 2023
Drug
Other Name(s): Mylotarg®
Jun 2022
Drug
Other Name(s): Xospata®
Jul 2023
Drug
Dec 2023
Drug
Other Name(s): Tepadina®
Jan 2023
Drug
Other Name(s): Trecondyv®
Jan 2025
Drug
Other Name(s): Asparlas®
Apr 2025
Drug
Other Name(s): Rydapt®
Jun 2025
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
New Drug Funding Program
    Teclistamab (Outpatient) - Relapsed or Refractory Multiple Myeloma
High Cost Therapy Funding Program
    Teclistamab (Inpatient) - Relapsed or Refractory Multiple Myeloma
Jul 2025

Pages